The Collagen Cliff
Thirty percent of skin collagen in five years. What menopause does to skin, and the four-year randomised trial that complicates the case for HRT.
Somewhere in the menopause transition, a great many women have the same experience, and almost none of them are warned about it.
The face changes faster than it ever has, and faster than ordinary ageing seems to account for. Skin that was reliable becomes dry. Firmness disappears. Lines that were faint settle in and stay.
It feels sudden, though nothing about ageing is sudden.
That experience corresponds to something measurable. It also sits directly alongside a piece of evidence most coverage omits, which rather changes what you should conclude.
The number, and its caveats
The figure you will encounter everywhere: around thirty percent of skin collagen in the first five years after menopause, followed by roughly two percent a year for the two decades after.
It comes from the British Menopause Society. For comparison, ordinary ageing takes about one to one and a half percent annually from your twenties onward.
So the shape is a steep loss stacked on a slow one. The slow decline has been running quietly for years. The steep one arrives inside a five-year window and accounts for a disproportionate share of the total.
Two caveats belong with it. The phrase collagen cliff is a social media coinage, though the underlying observation is old; researchers have been publishing on menopause and skin since at least the 1940s. And the range in the literature is wider than the headline suggests, with some sources placing most of the drop inside the first year or two rather than spread across five.
Why estrogen matters to skin
Because skin is an estrogen-responsive organ, and the cells that manufacture collagen carry receptors for it.
Estrogen switches on the genes producing collagen. It also increases hyaluronic acid production in the deeper layers, which is what holds water in your skin.
When estrogen falls, two processes move in opposite directions simultaneously. Production slows, because the signal instructing those cells to build has weakened. Meanwhile the clean-up process clearing out old collagen continues at its usual pace. Less arrives, the same amount departs, and the gap opens quickly.
That asymmetry is why it feels abrupt. Ageing has not accelerated. One side of a balance has simply been removed while the other carries on.
Does hormone therapy help your skin?
Here the evidence splits, and the split is worth understanding before deciding anything at all.
The case in favour. A 2023 systematic review and meta-analysis concluded that menopausal hormone therapy increases elasticity and collagen content, reducing wrinkle severity and increasing skin thickness. The authors added that better trials are needed. Supporting work reaches back to 1992, when Castelo-Branco and colleagues found postmenopausal women on hormone therapy carried higher skin collagen than controls, with the largest increase among those on transdermal estrogen.
The case against, which is stronger than most coverage admits. The Kronos Early Estrogen Prevention Study was randomised, double-blind and placebo-controlled. Women aged forty-two to fifty-eight, within three years of their last period, received oral estrogen, transdermal estrogen with progesterone, or placebo, for four years. Wrinkles were assessed at eleven sites on the face and neck and skin rigidity at forehead and cheek, annually.
Neither wrinkle score nor rigidity score differed significantly between the estrogen groups and placebo across four years.
A 1997 paper in Maturitas made the same point in its title: systemic estrogen therapy has no effect on skin collagen in postmenopausal women.
How to hold both
By separating what gets measured from what can be seen.
The favourable findings come largely from observational studies, smaller trials and meta-analyses pooling heterogeneous work. The null result comes from a four-year randomised trial with a placebo arm, which is the strongest design available and the one least vulnerable to the fact that women who take hormone therapy differ from women who do not in ways nobody can fully adjust for.
It is also entirely possible both are true. Hormone therapy may genuinely increase collagen content and skin thickness as measured on biopsy while producing no difference in wrinkles visible to an assessor. Change at tissue level does not automatically become change at the surface, particularly across four years in women relatively early in the transition.
The honest position is this. The mechanism is well established. The tissue-level evidence is reasonably supportive. The best-designed trial measuring what you can see found nothing. Hormone therapy is not prescribed for skin.
Anyone telling you it is a proven treatment for facial ageing is ahead of the evidence. So is anyone telling you it does nothing.
Topical estrogen
A smaller and more promising evidence base, with real safety questions attached.
A 2025 review in JAAD Reviews examined the topical evidence directly rather than extrapolating from systemic data, and found small trials showing collagen stimulation and thickening. One pilot study of fifteen postmenopausal women took facial biopsies before and after sixteen weeks of topical estradiol, and both thickness and collagen increased significantly.
The reasoning behind topical delivery is that applying estrogen to skin produces stronger local effects than systemic exposure, an observation dating to 1987, which positions it as potentially safer than systemic therapy.
The constraint is safety, and uptake remains limited because of it. Trials are small and long-term data is absent. This is a live research area and a conversation for a doctor who knows your history, rather than something to settle from an article.
What else changes
Three things beyond collagen, and they compound one another.
The barrier weakens, because less estrogen means less hyaluronic acid in the dermis, so hydration falls and resilience with it. This is why products that were fine for years suddenly sting.
Healing slows, which has practical consequences for anything involving controlled injury, and argues for gentler settings and longer intervals than you would have tolerated a decade earlier.
And skin thins, alongside disorganised elastic fibres and reduced collagen.
The combined effect is skin changing faster while tolerating less. Worth naming, because it runs directly against instinct. The moment the change becomes visible is the moment aggressive treatment is most tempting and least advisable.
What to do with all this
Treat the years before and during the transition as your highest-value window. If a disproportionate share of lifetime collagen loss occurs inside five years, the period leading into it is when protection compounds most, because the baseline it preserves is the one the loss will be subtracted from.
Do not choose hormone therapy for your skin. That decision involves vasomotor symptoms, bone density, cardiovascular risk and your own history, and it belongs with a doctor. Skin effects are, on the current evidence, an uncertain bonus rather than a reason.
And expect the change rather than reacting to it. The most common version of this story is a woman noticing rapid change, concluding something has gone wrong, and reaching for something aggressive at precisely the moment her skin is least resilient.
One last thing, and it is the part most easily missed. None of this was caused by anything you did. Collagen loss at menopause is an endocrine event rather than a consequence of insufficient effort. A great deal of marketing aimed at women in this window implies otherwise, and it is worth recognising the implication so that you can disregard it.
FAQ
How much collagen is lost at menopause?
Around 30 percent of skin collagen in the first five years is the figure usually cited, and it comes with real caveats about how it was measured.
Does HRT improve skin?
The mechanism is plausible and a four-year randomised trial complicates the simple version of the claim. Discuss it with your doctor as a whole-body decision rather than a skin one.
What else changes at menopause?
Dryness, a drop in firmness and faster settling of lines, alongside changes in barrier function.
References
- Skin Rejuvenation in Women using Menopausal Hormone Therapy: A Systematic Review and Meta-Analysis, Journal of Menopausal Medicine, 2023. Full text.
- Kronos Early Estrogen Prevention Study skin outcomes, and the 1997 Maturitas paper, both discussed here.
- Topical estrogen therapy for aging skin: current evidence and clinical considerations00103-5/fulltext), JAAD Reviews, 2025.
- Does menopause cause a "collagen cliff"? The Conversation, 2026.